CSIMarket
 



Candel Therapeutics Inc   (CADL)
Other Ticker:  
 
 



 

What are Candel Therapeutics Inc's Business Segments?



Candel Therapeutics Inc. is a biotechnology company specializing in developing and commercializing innovative immuno-oncology therapies. The company offers a range of segments, products, and services to address the needs of patients with various types of cancer. Here is a detailed description of the segments, products, and services provided by Candel Therapeutics Inc:

Segments:

1. Research and Development: This segment focuses on discovering and developing new treatment approaches for cancer. Candel Therapeutics Inc. invests in cutting-edge research to identify novel targets and therapeutic modalities.

2. Clinical Trials: The company conducts clinical trials to evaluate the safety and efficacy of its investigational therapies. They collaborate with healthcare institutions, hospitals, and research centers to conduct these trials efficiently.

3. Manufacturing and Supply Chain: Candel Therapeutics Inc. has a dedicated segment that oversees the manufacturing and supply of its therapies, ensuring quality, consistency, and timely distribution to patients and healthcare providers.

Products:

1. Oncolytic Viruses: Candel Therapeutics Inc. utilizes its proprietary oncolytic virus technology to create targeted therapies that selectively infect and destroy cancer cells while sparing healthy cells. These viruses are engineered to replicate within tumor cells, leading to their lysis and subsequent immune response against the cancer.

2. Immune Modulators: Candel Therapeutics Inc. develops immune modulators to enhance the body's immune response against cancer. These products aim to activate and boost the patient's immune system to recognize and eliminate cancer cells effectively.

Services:

1. Translational Research Services: Candel Therapeutics Inc. provides services to assist researchers in translating their discoveries into potential therapeutic applications. They offer expertise in preclinical models, drug development, and regulatory affairs to facilitate the advancement of novel treatments.

2. Biomarker Analysis and Testing: The company offers services to identify and assess specific biomarkers related to cancer, allowing for targeted treatment strategies and personalized medicine approaches. These services assist physicians in selecting the most appropriate treatment options for their patients.

3. Collaboration and Partnerships: Candel Therapeutics Inc. actively seeks collaborations and partnerships with academic institutions, pharmaceutical companies, and other stakeholders. They aim to foster scientific collaborations to accelerate research and development efforts in the field of immuno-oncology.

In summary, Candel Therapeutics Inc. is a biotechnology company that focuses on developing innovative immuno-oncology therapies. Their offerings include oncolytic viruses, immune modulators, translational research services, biomarker analysis, and collaboration opportunities. Through these products and services, Candel Therapeutics Inc. strives to revolutionize cancer treatment and improve patient outcomes.
   

Candel Therapeutics Inc Tax Rate Companies within the Biotechnology & Pharmaceuticals Industry



To get more information on Candel Therapeutics Inc's segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com